ACT1VATE: Addressing Emotional Distress to Improve Outcomes Among Diverse Adults With Type 1 Diabetes

Launched by SCRIPPS WHITTIER DIABETES INSTITUTE · Jun 14, 2021

Keywords

ClinConnect Summary

The ACT1VATE trial is studying how a special program called "ACT1VATE" can help adults with type 1 diabetes who are struggling with both their blood sugar control and emotional challenges related to diabetes. This program is compared to the usual diabetes education and support that people often receive. The goal is to see if the ACT1VATE program can lead to better health outcomes, improved emotional well-being, and possibly lower healthcare costs for those involved.

To join the trial, participants need to be adults aged 18 and older who speak either English or Spanish, have been diagnosed with type 1 diabetes, and have a recent blood sugar level (measured by a test called HbA1c) between 7.5% and 12.5%. They should also be feeling significant emotional distress related to their diabetes. It's important to note that people with serious medical or mental health issues that could interfere with their participation will not be eligible. Participants can expect to engage in online sessions and complete surveys about their experiences, and they will be supported throughout the process. This study is currently recruiting participants in the San Diego area.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Spanish or English-speaking
• • Type 1 diabetes
• • Glycosylated Hemoglobin (HbA1c) 7.5% - 12.5% in last 90 days
• • Screen positive for diabetes distress
• Exclusion Criteria:
• • Severe medical or psychological conditions that would interfere with participation based on the opinion of a provider
• • Plans to move out of the San Diego area in the next 12 months
• • Lack of technology capability required to complete online surveys and telemedicine visit